| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $432K | +215.9% |
| Cost of Revenue | $100K | -23.4% |
| Gross Profit | $331K | +5420.1% |
| R&D Expense | $2.0M | -12.5% |
| SG&A Expense | $7.9M | +18.7% |
| Operating Income | -$42.6M | -189.7% |
| Pre-tax Income | -$43.5M | -131.7% |
| Income Tax | -$2.0M | -273.3% |
| Net Income | -$41.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | — |
| Accounts Receivable | $731K | +6485.0% |
| Inventory | $213K | — |
| Current Assets | $7.9M | +25.5% |
| Total Assets | $84.2M | -19.7% |
| Current Liabilities | $2.7M | -65.4% |
| Long-term Debt | $2.9M | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | +6.2% |
| Capital Expenditures | $12K | +0.0% |
| Investing Cash Flow | $27.6M | +0.0% |
| Financing Cash Flow | $19.7M | +252.0% |
| Free Cash Flow | -$13.4M | +6.2% |
| -557.9% |
| EPS (Basic) | -$2.70 | -200.4% |
| EPS (Diluted) | -$2.70 | -208.9% |
| Total Liabilities |
| $14.1M |
| -45.5% |
| Stockholders' Equity | $70.1M | -11.3% |